King JC Jr - Search Results

1

Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or older.

Wolfe DN, Espeland EM, Gao Y, Lu D, Blatner G, Amass K, Horwith G, Tong XM, Hopkins R, David GL, Jepson BM, King JC Jr. Wolfe DN, et al. Among authors: king jc jr. Vaccine. 2020 Nov 25;38(50):7970-7976. doi: 10.1016/j.vaccine.2020.10.053. Epub 2020 Oct 28. Vaccine. 2020. PMID: 33129609 Free article.

2

Evaluation of anthrax vaccine safety in 18 to 20 year olds: A first step towards age de-escalation studies in adolescents.

King JC Jr, Gao Y, Quinn CP, Dreier TM, Vianney C, Espeland EM. King JC Jr, et al. Vaccine. 2015 May 15;33(21):2470-6. doi: 10.1016/j.vaccine.2015.03.071. Epub 2015 Apr 5. Vaccine. 2015. PMID: 25850022 Free PMC article.

3

Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.

King JC Jr, Lichenstein R, Magder LS. King JC Jr, et al. Vaccine. 2013 Jan 21;31(5):839-44. doi: 10.1016/j.vaccine.2012.11.054. Epub 2012 Dec 4. Vaccine. 2013. PMID: 23219798

4

The relationship between influenza outbreaks and acute ischemic heart disease in Maryland residents over a 7-year period.

Lichenstein R, Magder LS, King RE, King JC Jr. Lichenstein R, et al. Among authors: king jc jr. J Infect Dis. 2012 Sep 15;206(6):821-7. doi: 10.1093/infdis/jis435. Epub 2012 Jul 12. J Infect Dis. 2012. PMID: 22798684

5

Pediatrician attitudes concerning school-located vaccination clinics for seasonal influenza.

Keane VA, Hudson AR, King JC Jr. Keane VA, et al. Among authors: king jc jr. Pediatrics. 2012 Mar;129 Suppl 2:S96-S100. doi: 10.1542/peds.2011-0737I. Pediatrics. 2012. PMID: 22383488

6

Successful use of volunteers to conduct school-located mass influenza vaccination clinics.

Cummings GE, Ruff E, Guthrie SH, Hoffmaster MA, Leitch LL, King JC Jr. Cummings GE, et al. Among authors: king jc jr. Pediatrics. 2012 Mar;129 Suppl 2:S88-95. doi: 10.1542/peds.2011-0737H. Pediatrics. 2012. PMID: 22383487

7

Direct and indirect impact of influenza vaccination of young children on school absenteeism.

King JC Jr, Beckett D, Snyder J, Cummings GE, King BS, Magder LS. King JC Jr, et al. Vaccine. 2012 Jan 5;30(2):289-93. doi: 10.1016/j.vaccine.2011.10.097. Epub 2011 Nov 12. Vaccine. 2012. PMID: 22085547

8

Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland.

King JC Jr, Lichenstein R, Cummings GE, Magder LS. King JC Jr, et al. Vaccine. 2010 Nov 16;28(49):7737-42. doi: 10.1016/j.vaccine.2010.09.064. Epub 2010 Oct 8. Vaccine. 2010. PMID: 20933566

9

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.

King JC Jr, Cox MM, Reisinger K, Hedrick J, Graham I, Patriarca P. King JC Jr, et al. Vaccine. 2009 Nov 5;27(47):6589-94. doi: 10.1016/j.vaccine.2009.08.032. Epub 2009 Aug 27. Vaccine. 2009. PMID: 19716456 Clinical Trial.

10

Countywide school-based influenza immunization: direct and indirect impact on student absenteeism.

Davis MM, King JC Jr, Moag L, Cummings G, Magder LS. Davis MM, et al. Among authors: king jc jr. Pediatrics. 2008 Jul;122(1):e260-5. doi: 10.1542/peds.2007-2963. Pediatrics. 2008. PMID: 18595972

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters